A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687)
Howard Hochster, Ruth Oratz, David S. Ettinger, Ernest BordenVolume:
16
Year:
1998
Language:
english
Pages:
5
DOI:
10.1023/a:1006110431250
File:
PDF, 56 KB
english, 1998